Sonova
Skip navigation links
About Sonova
Investors
Media
Commitments
Search & Quick Access
Key Figures 

 

 

in 1,000 CHF unless otherwise specified

 

 

2010/11

 

 

2009/101)

Sales

1,616,700

1,500,306

change compared to previous year (%)

7.8

20.1

Gross profit

1,118,681

1,058,427

change compared to previous year (%)

5.7

22.1

in % of sales

69.2

70.6

Research & development costs

107,760

87,034

in % of sales

6.7

5.8

Sales & marketing costs

498,589

402,626

in % of sales

30.8

26.8

Operating profit before acquisition-related amortization (EBITA)

 

326,622

 

420,106

change compared to previous year (%)

-22.3

26.7

in % of sales

20.2

28.0

Operating profit (EBIT) 

270,810

251,419

change compared to previous year (%)

7.7

-22.6

in % of sales

16.8

16.8

Income after taxes 

231,080

216,632

change compared to previous year (%)

6.7

-23.8

in % of sales

14.3

14.4

Number of employees (average)

7,291

5,933

change compared to previous year (%)

22.9

16.1

Number of employees (end of period)

7,840

6,843

change compared to previous year (%)

14.6

28.2

Net cash2)

-111,287-

-126,029

Net working capital3)

158,190

144,363

in % of sales

9.8

9.6

Capital expenditure

(tangible and intangible assets)4)

 

111,457

 

89,272

Capital employed5)

1,455,999

1,388,537

in % of sales

90.1

92.6

Total assets

2,171,644

2,324,026

Equity

1,344,712

1,262,508

Equity financing ratio (%)6)

61.9

54.3

Free cash flow7)

71,593

-301,388

Operating free cash flow8)

221,541

324,754

in % of sales

13.7

21.6

Return on capital employed (%)9)

19.0

23.0

Return on equity (%)10)

17.7

18.9

Basic earnings per share (CHF)

3.50

3.32

Diluted earnings per share (CHF)

3.47

3.28

Cash-based basic earnings per share (CHF)11)

4.27

5.61

Dividend per share (CHF)

1.20

1.20

1) Restated based on finalization of the aquisition accounting of Advanced Bionics (for details refer to Note 3.7).

2) Cash and cash equivalents + other current financial assets (excl. loans) – short-term debts – other current financial liabilities – non-current financial liabilities.
3) Receivables (incl. loans) + inventories – trade payables – current income tax liabilities – other short-term liabilities – short-term provisions.
4) Excluding goodwill and intangibles relating to acquisitions.
5) Total assets – cash and cash equivalents – other current financial assets (excl. loans) – trade payables – other liabilities – provisions – tax liabilities.
6) Equity in % of total assets.
7) Cash flow from operating activities + cash flow from investing activities.
8) Free cash flow – cash consideration for acquisitions, net of cash acquired.
9) EBIT in % of capital employed (average).
10) Income after taxes in % of equity (average).
11) Excluding the amortization of acquisition-related intangibles and unwinding effect of the discount on acquisition-related earn-out payments, net  of tax.

 

 Key Figures 

 

 
 
Impressum  Disclaimer  Print Page  Add to Favorites
Copyright © 2007 Sonova All rights reserved. Please read our legal information.
Last modified: 31.08.2011
Copyright © 2007 Sonova All rights reserved. Please read our legal information.
Last modified: 31.08.2011